STUDIES ON FIXED DOSE COMBINATION OF IBRUTINIB AND QUERCETIN SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEMS IN HUMAN CANCER CELL LINES. Int. J. Pharm. Sci. Drug Res. [Internet]. 2023 Nov. 30 [cited 2025 Oct. 17];15(6):764-9. Available from: https://ijpsdronline.com/index.php/journal/article/view/8011